1. Home
  2. VYGR vs CMT Comparison

VYGR vs CMT Comparison

Compare VYGR & CMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • CMT
  • Stock Information
  • Founded
  • VYGR 2013
  • CMT 1996
  • Country
  • VYGR United States
  • CMT United States
  • Employees
  • VYGR N/A
  • CMT N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • CMT Electronic Components
  • Sector
  • VYGR Health Care
  • CMT Consumer Discretionary
  • Exchange
  • VYGR Nasdaq
  • CMT Nasdaq
  • Market Cap
  • VYGR 172.6M
  • CMT 147.1M
  • IPO Year
  • VYGR 2015
  • CMT N/A
  • Fundamental
  • Price
  • VYGR $3.19
  • CMT $16.64
  • Analyst Decision
  • VYGR Strong Buy
  • CMT
  • Analyst Count
  • VYGR 8
  • CMT 0
  • Target Price
  • VYGR $14.33
  • CMT N/A
  • AVG Volume (30 Days)
  • VYGR 647.7K
  • CMT 21.9K
  • Earning Date
  • VYGR 08-12-2025
  • CMT 08-05-2025
  • Dividend Yield
  • VYGR N/A
  • CMT N/A
  • EPS Growth
  • VYGR N/A
  • CMT N/A
  • EPS
  • VYGR N/A
  • CMT 1.33
  • Revenue
  • VYGR $66,958,000.00
  • CMT $285,680,000.00
  • Revenue This Year
  • VYGR N/A
  • CMT N/A
  • Revenue Next Year
  • VYGR $78.89
  • CMT $1.14
  • P/E Ratio
  • VYGR N/A
  • CMT $12.52
  • Revenue Growth
  • VYGR N/A
  • CMT N/A
  • 52 Week Low
  • VYGR $2.65
  • CMT $12.25
  • 52 Week High
  • VYGR $9.55
  • CMT $19.20
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 48.20
  • CMT 45.06
  • Support Level
  • VYGR $3.15
  • CMT $16.98
  • Resistance Level
  • VYGR $3.79
  • CMT $17.75
  • Average True Range (ATR)
  • VYGR 0.21
  • CMT 0.44
  • MACD
  • VYGR 0.00
  • CMT -0.06
  • Stochastic Oscillator
  • VYGR 16.67
  • CMT 12.60

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About CMT Core Molding Technologies Inc

Core Molding Technologies Inc operates in the engineered materials market as one operating segment as a molder of thermoplastic and thermoset structural products. It produces and sells molded products for varied markets, including medium and heavy-duty trucks, automobiles, power sports, construction and agriculture, building products, and other industrial markets. The processes include compression molding of sheet molding compound (SMC), resin transfer molding (RTM), liquid molding of dicyclopentadiene (DCPD), spray-up and hand-lay-up, direct long-fiber thermoplastics (D-LFT) and structural foam, and structural web injection molding (SIM). It operates operates in Columbus, Ohio; Gaffney, South Carolina; Winona, Minnesota; Matamoros and Escobedo, Mexico; and Cobourg, Ontario, Canada.

Share on Social Networks: